世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

2021年バイオテクノロジー研究レビュー


2021 Biotechnology Research Review

レポートハイライト - エクソソーム診断薬および治療薬の世界市場は、2021年の9780万ドルから2026年には5億1260万ドルに成長し、2021年から2026年の年平均成長率(CAGR)は39.3%となる見込みです。 - バイオ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
BCC Research
BCCリサーチ
2022年2月25日 US$3,000
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
312 英語

 

サマリー

レポートハイライト

- エクソソーム診断薬および治療薬の世界市場は、2021年の9780万ドルから2026年には5億1260万ドルに成長し、2021年から2026年の年平均成長率(CAGR)は39.3%となる見込みです。
- バイオインフォマティクスの世界市場は、2020年の161億ドルから2025年には241億ドルに成長し、2020年から2025年の期間は年平均成長率(CAGR)8.4%で推移するものと思われます。
- 細胞・遺伝子治療の世界市場は、2021年の41億ドルから2026年には174億ドルに成長し、2021年から2026年までの年平均成長率(CAGR)は33.6%となる見通しです。

バイオテクノロジー市場全体の成長を加速させる重要な開発が数多く行われています。これらの注目すべき最近の進歩には、mRNA治療薬、CRISPR技術、バイオセンサーおよびバイオプリンティング技術、がん幹細胞研究、細胞および遺伝子治療と並ぶDNAワクチンなどがあります。これらの進歩は、医薬品開発をサポートする細胞株技術の幅広い採用を保証し、遺伝子編集プロセスの簡素化により、長期的に費用対効果が高くなります。

分子生物学の進歩は、分子・計算機ツールやソフトウェアの提供を支えています。合成生物学は、生きている細胞内の遺伝物質の製造や改変を促進するもう一つの応用分野である。

他の産業とは異なり、バイオテクノロジー産業はパンデミックの間中、高い成長を遂げてきました。COVID-19の診断治療法の模索は、政府、メディア、一般市民を問わず科学と医学に注目させ、バイオテクノロジー企業の買収や提携が堅実な投資であるという考えを強めています。細胞株市場で事業を展開する企業は現在、多額の投資を行い、高度で最新のリソースを備えた製造装置の開発や設備の拡充を可能にしている。同時に、遺伝子配列解析技術は、特に様々な癌やコロナウイルス株の診断において、ヘルスケア部門全体で大きなペースで進歩しています。

2019年、2020年のバイオテクノロジー業界は、ベンチャーキャピタルからの資金調達、提携、共同開発、ジョイントベンチャーなどにより、年間2桁の成長が見込まれています。しかし、この分野では、マーケティング、イノベーションのための資金調達、政府組織からの価格圧力に関連する困難が続いています。また、開発コストも課題であり、メーカーにとって最も重要な問題であることが多い。単純なコレステロールの薬なら1日5ドル(年間約1,825ドル)ですが、バイオ医薬品の場合は年間2万ドル以上かかる場合もあります。

2019年、遺伝子治療や細胞生物学の技術開発に成功したが、これには高いコストがかかっていた。例えば、脊髄性筋萎縮症の治療のためのウイルスベクターベースの遺伝子治療であるゾルゲンスマは、約500万ドルもします。メーカーにとって最も難しいのは、技術革新にかかるコストのバランスをどう取るかです。価格設定を適切に行うこと、そして製品を市場に送り出すためのコストもまた、極めて重要な課題です。イノベーションは、臨床試験段階から市場に出るまで数年かかることもあり、最初から期待に応えなければ、投資家は失望し、株価が下がるかもしれません。

本バイオテクノロジーリサーチレビューは、1971年のBCCリサーチ設立以来、ビジネスの意思決定を支援してきた定量的な市場情報、分析、ガイダンスの一例を提供するものです。以下のバイオテクノロジー市場に関する2021年に出版されたレポートのハイライトを含んでいます。
- BIO149D エクソソーム診断と治療法。世界市場
- BIO051F バイオインフォマティクス。テクノロジーとグローバル市場
- BIO225A 細胞・遺伝子治療の世界市場
- BIO126D 次世代シーケンサー。新たな臨床応用と世界市場
- BIO083D ライフサイエンスツールと試薬グローバル市場
- BIO045H Global DNA Sequencing:研究、応用、臨床の各市場
- BIO212A mRNA:治療薬と世界市場
- BIO158B がん幹細胞。テクノロジーと世界市場
- BIO150D リキッドバイオプシーの研究ツール、サービス、診断。世界市場
- BIO135D 人工多能性幹細胞。世界市場
- BIO141C 研究用抗体の世界市場
- BIO211A 細胞療法のバイオマニュファクチャリング。グローバル市場

本レポートを是非ご覧ください。本レポートに掲載されている市場調査レポート全文を入手されることをお勧めします。BCCリサーチでは、今後もお客様のマーケットインテリジェンスのニーズにお応えできるよう努力してまいります。

ページTOPに戻る


目次

Table of Contents
Chapter 1 Foreword
Foreword
Chapter 2 Exosome Diagnostics and Therapeutics: Global Markets (BIO149D)
Introduction
Study Goals and Objectives
Scope of Report
Information Sources
Intended Audience
Related BCC Research Reports
Summary and Highlights
Market Overview
Exosome Definition and Nomenclature
Exosome Components
Exosome and COVID-19 Treatment
Exosome Diagnostic Market
Exosome Therapeutic Market
Market Breakdown by End User
Market Breakdown by Region
Patent Analysis
U.S. Patent Analysis
European Patent Analysis
Pipeline Analysis
Chapter 3 Bioinformatics: Technologies and Global Markets (BIO051F)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Research Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Market Trends
Market Breakdown
Global Market for Bioinformatics by Sequencing Services and Platforms
Global Market for Bioinformatics by Solution
Global Market for Bioinformatics by End User
Global Market for Bioinformatics by Region
Bioinformatics Applications in Pharmaceutical R&D
Drug Discovery and Development Process
Clinical Research: Drug Development
Post-Launch Ongoing Studies and Phase IV Clinical Trials
Recent Pharmaceutical and Bioinformatics Alliances and Partnerships
Conclusions
Chapter 4 Global Cell and Gene Therapy Market (BIO225A)
Introduction
Study Goals and Objectives
Scope of This Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Highlights of the Market for Cell and Gene Therapy
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Market Breakdown by Product
Market Breakdown by Application
Market Breakdown by Region
Pipeline Analysis
Drugs Pending Approval
Competitive Landscape: Overview
Market Share Analysis
Strategic Acquisitions and Collaborations
Chapter 5 Next-generation Sequencing: Emerging Clinical Applications and Global Markets (BIO126D)
Introduction
Study Goals and Objectives
Reasons for Doing the Study
Scope of Report
Methodology
Information Sources
Geographical Breakdown
Analyst’s Credentials
Related BCC Research Reports
Summary and Highlights
Next-generation Sequencing and Markets
Clinical NGS Testing Market
Growth Drivers of Clinical NGS
Key Trends
Industry
Sequencing Technologies
History of DNA Sequencing
Clinical NGS Markets
Market Dynamics
Clinical NGS Market by Disease Category
Clinical NGS Market by Complexity
Clinical NGS Market by Test Purpose
Geographical Markets
Chapter 6 Life Science Tools and Reagents: Global Markets (BIO083D)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Market Dynamics
Market Drivers
Market Restraints and Challenges
Market Opportunities
Global Market for Life Science Tools and Reagents, by End-User Application
Global Market for Life Science Tools and Diagnostics, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045H)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Analyst's Credentials
Related BCC Research Reports
Summary and Highlights
Overview
Sequencing Growth Driving Forces
Research and Applied Applications
Clinical Applications
Market for DNA Sequencing
Market Breakdown by Major Segment
Geographical Markets
Chapter 8 mRNA: Therapeutics and Global Markets (BIO212A)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources and Methodology
Intended Audience
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Summary and Highlights
Market Situation for RNA Therapeutics
Well-Developed Markets
Developing Markets
Underdeveloped Markets
mRNA Vaccines
Clinical Need for mRNA Vaccines
mRNA Vaccines and Types by Application
Marketed/Commercial mRNA Vaccines
mRNA Vaccines: New Developments
mRNA Vaccines and Future Pandemics
mRNA Drugs and Therapies
Clinical Need for mRNA Therapeutics Beyond Vaccines
mRNA as Gene and Protein Replacement Therapy
mRNA-Enhanced Cell Therapies
mRNA-Enhanced Immunotherapies (Monoclonal Antibody)
mRNA Drugs for Protein Therapy Targeting Metabolic and Rare Diseases
mRNA Therapeutics and New Developments
Market Size and Growth Analysis by Product Segment
Market Size and Growth Analysis by Therapeutic Application
Market Size and Growth Analysis by Disease Type
SWOT Analysis of the Market for mRNA Therapeutics
Chapter 9 Cancer Stem Cells: Technologies and Global Markets (BIO158B)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources & Methodology
Geographic Breakdown
Analyst’s Credentials
Related BCC Research Reports
Summary and Highlights
Market Dynamics
Drivers
Restraints
Opportunity
Market Breakdown by Region
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Chapter 10 Global Markets for Research Antibodies (BIO141C)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Trends in the Market for Research Antibodies
Purchasing Factors Analysis
Third-Party Quality Evaluation Systems
Research Grants
Global Market for Research Antibodies by Product
Global Market for Research Antibodies by Clonality
Global Market for Research Antibodies by Major Reactivities
Global Market for Research Antibodies by Host Species
Global Market for Research Antibodies by End User
Global Market for Research Antibodies by Region
Global Company Market Ranking Analysis
Chapter 11 Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets (BIO150D)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials
Related BCC Research Reports
Summary and Highlights
Industry Overview
Forces Driving Growth
Key Trends
Liquid Biopsy Initiatives
Global Market for Liquid Biopsy by Clinical Category
Global Market for Non-invasive Prenatal Testing
Global Market for Liquid Biopsy for Cancer Diagnostics
Global Market for Liquid Biopsy for Transplant Diagnostics
Global Market for Liquid Biopsy by Purpose of Analysis
Global Market for Liquid Biopsy by Biomarker Type
Global Market for Liquid Biopsy by Analysis Platform
Global Market for Liquid Biopsy by Geographic Region
Chapter 12 Induced Pluripotent Stem Cells: Global Markets (BIO135D)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Key Drivers for Market Growth
Technology Overview
Induced Pluripotent Stem Cell Generation
Induced Pluripotent Stem Cell Differentiation
Current Challenges to iPSC Applications
iPSCs Bank
Impact of COVID-19 on iPSCs
Pluripotent Stem Cells as a Study Model for COVID-19
Scientists Use Stem Cells to Uncover COVID-19 Effects on the Heart
Market Overview
Market Breakdown by Region
Market Breakdown by Reprogramming Method
Market Breakdown by Application
Market Breakdown by Product
Induced Pluripotent Stem Cell-Derived Tissue Cell Market
Induced Pluripotent Stem Cells and Their Derivative Cell Market by Species
Market for Induced Pluripotent Stem Cells Derived Cell Market by Application
Market for Induced Pluripotent Stem Cells by Product Function
Research Market Compared with the Clinical Market
Major Suppliers and Manufacturers of Induced Pluripotent Stem Cell Products
Induced Pluripotent Stem Cell Contract Service Types
Market Shares and Projections
Chapter 13 Cell Therapy Biomanufacturing: Global Markets (BIO211A)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Market Breakdown by Application
Market Breakdown by Region
Market Trends & Challenges
Drivers
Restraints
Opportunity
Challenges

 

ページTOPに戻る


 

Summary

Report Highlights:

- The global market for exosome diagnostics and therapeutics should grow from $97.8 million in 2021 to $512.6 million by 2026, at compound annual growth rate (CAGR) of 39.3% for the period of 2021-2026.
- The global market for bioinformatics should grow from $16.1 billion in 2020 to $24.1 billion by 2025 with a compound annual growth rate (CAGR) of 8.4% for the period of 2020-2025.
- The global market for cell and gene therapy should grow from $4.1 billion in 2021 to $17.4 billion by 2026 with a compound annual growth rate (CAGR) of 33.6% for the period of 2021-2026.

There have been a number of significant developments that has accelerated growth across the biotechnology market. These notable recent advancements include, mRNA therapeutics, CRISPR technology, biosensors and bioprinting technologies, cancer stem cell research, alongside cell and gene therapy and DNA vaccines. These advancements ensure the wide adoption of cell line technologies that support drug development and the simplification of the gene editing process, making it more cost effective long-term.

Advancement in molecular biology is supporting the delivery of molecular and computational tools and software. Synthetic biology is another field of application that promotes the manufacturing of and/or modification of genetic material in living cells.

Unlike other industries, the biotech industry has witnessed high growth throughout the pandemic. The search for diagnostic treatment methods for COVID-19 has forced governments, the media and the general public alike to focus on science and medicine, strengthening the idea that biotech acquisitions and partnerships are solid investments. Companies operating in the cell line market are now investing large amounts, enabling the development of manufacturing units with advanced, state of the art resources and expanded facilities. At the same time, genetic sequencing technology is advancing at a great pace, especially across the healthcare sector in the diagnosis of various cancers and strains of Coronavirus.

In 2019 and 2020, the biotech industry saw double digit annual growth due to fundraising from venture capitals, partnerships, co-development and joint ventures. However, the sector does continuous challenging relating to marketing, funding for innovation and pricing pressures from government organizations. Development costs are also a challenge, and often the most critical for manufacturers. While a simple cholesterol drug may cost $5 per day (approximately $1,825 per annum), a biotech drug may cost around $20,000 or more a year.

In 2019, gene therapy and cell biology technologies were successfully developed, however, this came at a high cost. For example, Zolgensma, a viral vector-based gene therapy for the treatment of spinal muscular atrophy costs around $5 million. It is important for manufacturers to figure out how to balance the cost of innovation that proves most challenging. Getting the pricing right, and the costs involved with getting the products to market are also vital challenges. Innovation may take several years to move from a clinical trial phase to market launch, and investors may face disappointment and falling stock if expectations are not managed from the offset.

This Biotechnology Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making since BCC Research was founded in 1971. It includes highlights of reports published in 2021 on the following biotech markets -
- BIO149D Exosome Diagnostics and Therapeutics: Global Markets
- BIO051F Bioinformatics: Technologies and Global Markets
- BIO225A Global Cell and Gene Therapy Market
- BIO126D Next-generation Sequencing: Emerging Clinical Applications and Global Markets
- BIO083D Life Science Tools and Reagents: Global Markets
- BIO045H Global DNA Sequencing: Research, Applied and Clinical Markets
- BIO212A mRNA: Therapeutics and Global Markets
- BIO158B Cancer Stem Cells: Technologies and Global Markets
- BIO150D Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
- BIO135D Induced Pluripotent Stem Cells: Global Markets
- BIO141C Global Markets for Research Antibodies
- BIO211A Cell Therapy Biomanufacturing: Global Markets

We hope you find this Research Review valuable. We encourage you to obtain and benefit from the full market research reports that are excerpted in this Research Review. BCC Research looks forward to serving your market intelligence needs in the future.



ページTOPに戻る


Table of Contents

Table of Contents
Chapter 1 Foreword
Foreword
Chapter 2 Exosome Diagnostics and Therapeutics: Global Markets (BIO149D)
Introduction
Study Goals and Objectives
Scope of Report
Information Sources
Intended Audience
Related BCC Research Reports
Summary and Highlights
Market Overview
Exosome Definition and Nomenclature
Exosome Components
Exosome and COVID-19 Treatment
Exosome Diagnostic Market
Exosome Therapeutic Market
Market Breakdown by End User
Market Breakdown by Region
Patent Analysis
U.S. Patent Analysis
European Patent Analysis
Pipeline Analysis
Chapter 3 Bioinformatics: Technologies and Global Markets (BIO051F)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Research Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Market Trends
Market Breakdown
Global Market for Bioinformatics by Sequencing Services and Platforms
Global Market for Bioinformatics by Solution
Global Market for Bioinformatics by End User
Global Market for Bioinformatics by Region
Bioinformatics Applications in Pharmaceutical R&D
Drug Discovery and Development Process
Clinical Research: Drug Development
Post-Launch Ongoing Studies and Phase IV Clinical Trials
Recent Pharmaceutical and Bioinformatics Alliances and Partnerships
Conclusions
Chapter 4 Global Cell and Gene Therapy Market (BIO225A)
Introduction
Study Goals and Objectives
Scope of This Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Highlights of the Market for Cell and Gene Therapy
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Market Breakdown by Product
Market Breakdown by Application
Market Breakdown by Region
Pipeline Analysis
Drugs Pending Approval
Competitive Landscape: Overview
Market Share Analysis
Strategic Acquisitions and Collaborations
Chapter 5 Next-generation Sequencing: Emerging Clinical Applications and Global Markets (BIO126D)
Introduction
Study Goals and Objectives
Reasons for Doing the Study
Scope of Report
Methodology
Information Sources
Geographical Breakdown
Analyst’s Credentials
Related BCC Research Reports
Summary and Highlights
Next-generation Sequencing and Markets
Clinical NGS Testing Market
Growth Drivers of Clinical NGS
Key Trends
Industry
Sequencing Technologies
History of DNA Sequencing
Clinical NGS Markets
Market Dynamics
Clinical NGS Market by Disease Category
Clinical NGS Market by Complexity
Clinical NGS Market by Test Purpose
Geographical Markets
Chapter 6 Life Science Tools and Reagents: Global Markets (BIO083D)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Market Dynamics
Market Drivers
Market Restraints and Challenges
Market Opportunities
Global Market for Life Science Tools and Reagents, by End-User Application
Global Market for Life Science Tools and Diagnostics, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045H)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Analyst's Credentials
Related BCC Research Reports
Summary and Highlights
Overview
Sequencing Growth Driving Forces
Research and Applied Applications
Clinical Applications
Market for DNA Sequencing
Market Breakdown by Major Segment
Geographical Markets
Chapter 8 mRNA: Therapeutics and Global Markets (BIO212A)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources and Methodology
Intended Audience
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Summary and Highlights
Market Situation for RNA Therapeutics
Well-Developed Markets
Developing Markets
Underdeveloped Markets
mRNA Vaccines
Clinical Need for mRNA Vaccines
mRNA Vaccines and Types by Application
Marketed/Commercial mRNA Vaccines
mRNA Vaccines: New Developments
mRNA Vaccines and Future Pandemics
mRNA Drugs and Therapies
Clinical Need for mRNA Therapeutics Beyond Vaccines
mRNA as Gene and Protein Replacement Therapy
mRNA-Enhanced Cell Therapies
mRNA-Enhanced Immunotherapies (Monoclonal Antibody)
mRNA Drugs for Protein Therapy Targeting Metabolic and Rare Diseases
mRNA Therapeutics and New Developments
Market Size and Growth Analysis by Product Segment
Market Size and Growth Analysis by Therapeutic Application
Market Size and Growth Analysis by Disease Type
SWOT Analysis of the Market for mRNA Therapeutics
Chapter 9 Cancer Stem Cells: Technologies and Global Markets (BIO158B)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources & Methodology
Geographic Breakdown
Analyst’s Credentials
Related BCC Research Reports
Summary and Highlights
Market Dynamics
Drivers
Restraints
Opportunity
Market Breakdown by Region
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Chapter 10 Global Markets for Research Antibodies (BIO141C)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Trends in the Market for Research Antibodies
Purchasing Factors Analysis
Third-Party Quality Evaluation Systems
Research Grants
Global Market for Research Antibodies by Product
Global Market for Research Antibodies by Clonality
Global Market for Research Antibodies by Major Reactivities
Global Market for Research Antibodies by Host Species
Global Market for Research Antibodies by End User
Global Market for Research Antibodies by Region
Global Company Market Ranking Analysis
Chapter 11 Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets (BIO150D)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials
Related BCC Research Reports
Summary and Highlights
Industry Overview
Forces Driving Growth
Key Trends
Liquid Biopsy Initiatives
Global Market for Liquid Biopsy by Clinical Category
Global Market for Non-invasive Prenatal Testing
Global Market for Liquid Biopsy for Cancer Diagnostics
Global Market for Liquid Biopsy for Transplant Diagnostics
Global Market for Liquid Biopsy by Purpose of Analysis
Global Market for Liquid Biopsy by Biomarker Type
Global Market for Liquid Biopsy by Analysis Platform
Global Market for Liquid Biopsy by Geographic Region
Chapter 12 Induced Pluripotent Stem Cells: Global Markets (BIO135D)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Key Drivers for Market Growth
Technology Overview
Induced Pluripotent Stem Cell Generation
Induced Pluripotent Stem Cell Differentiation
Current Challenges to iPSC Applications
iPSCs Bank
Impact of COVID-19 on iPSCs
Pluripotent Stem Cells as a Study Model for COVID-19
Scientists Use Stem Cells to Uncover COVID-19 Effects on the Heart
Market Overview
Market Breakdown by Region
Market Breakdown by Reprogramming Method
Market Breakdown by Application
Market Breakdown by Product
Induced Pluripotent Stem Cell-Derived Tissue Cell Market
Induced Pluripotent Stem Cells and Their Derivative Cell Market by Species
Market for Induced Pluripotent Stem Cells Derived Cell Market by Application
Market for Induced Pluripotent Stem Cells by Product Function
Research Market Compared with the Clinical Market
Major Suppliers and Manufacturers of Induced Pluripotent Stem Cell Products
Induced Pluripotent Stem Cell Contract Service Types
Market Shares and Projections
Chapter 13 Cell Therapy Biomanufacturing: Global Markets (BIO211A)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Market Breakdown by Application
Market Breakdown by Region
Market Trends & Challenges
Drivers
Restraints
Opportunity
Challenges

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオマス)の最新刊レポート

BCC Research社のバイオマス分野での最新刊レポート


よくあるご質問


BCC Research社はどのような調査会社ですか?


BCCリサーチ(BCC Research)は1971年に設立され、様々な業界経験を持つアナリストと編集者によりトップクラスの市場情報源を長年提供している調査会社です。   設立初期は先端材料とプラ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る